Cargando…

Improving VEGF-targeted therapies through inhibition of COX-2/PGE(2) signaling

Antiangiogenic agents targeting the vascular endothelial growth factor A (VEGFA) pathway play an important role in current cancer treatment modalities but are limited by alternative angiogenesis mechanisms. Recent studies suggest that enhanced signaling through a COX-2/PGE(2) axis contributes to VEG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lihong, Croix, Brad St.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905212/ https://www.ncbi.nlm.nih.gov/pubmed/27308371 http://dx.doi.org/10.4161/23723548.2014.969154

Ejemplares similares

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012)

Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillance
por: Markosyan, Nune, et al.
Publicado: (2014)

COX2 regulation of breast cancer bone metastasis
por: Karavitis, John, et al.
Publicado: (2013)

Resistance to kinase inhibition through shortened target engagement
por: Rangwala, Aziz M., et al.
Publicado: (2022)

VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis
por: Karali, Evdoxia, et al.
Publicado: (2014)

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
por: Hansen, Wiebke
Publicado: (2013)

Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy
por: Lazear, Eric, et al.
Publicado: (2017)

Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibition
por: Codarri Deak, Laura, et al.
Publicado: (2023)

Targeting MYC through WDR5
por: Thomas, Lance R., et al.
Publicado: (2020)

GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)

BRAF-targeted therapy alters the functions of intratumoral CD4(+) T cells to inhibit melanoma progression
por: Ho, Ping-Chih, et al.
Publicado: (2014)

The ELR(+)CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma
por: Giuliano, Sandy, et al.
Publicado: (2014)

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
por: Terme, Magali, et al.
Publicado: (2013)

Inhibition of RANK signaling as a potential immunotherapy in breast cancer
por: Gómez-Aleza, C, et al.
Publicado: (2021)

Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
por: Suryawanshi, Amol, et al.
Publicado: (2015)

Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
por: Rudqvist, Nils-Petter, et al.
Publicado: (2023)

Resveratrol treatment inhibits acute pharyngitis in the mice model through inhibition of PGE2/COX-2 expression
por: Yu, Zhaoyan, et al.
Publicado: (2018)

UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
por: Esteves, Pauline, et al.
Publicado: (2014)

COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020)

ERK1/2/COX-2/PGE(2) signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes
por: Li, Tingting, et al.
Publicado: (2014)

Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition
por: Popova, Semiramis A., et al.
Publicado: (2018)

Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition
por: López-Soto, Alejandro, et al.
Publicado: (2013)

Improving the outcome of adoptive cell transfer by targeting tumor escape
por: Kaluza, Karen M., et al.
Publicado: (2013)

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
por: Kmiecik, Justyna, et al.
Publicado: (2014)

A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)

The Wae to repair: prostaglandin E2 (PGE(2)) triggers intestinal wound repair
por: Jackstadt, Rene, et al.
Publicado: (2017)

Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth
por: Dentelli, Patrizia, et al.
Publicado: (2014)

Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
por: Croci, Diego O, et al.
Publicado: (2014)

TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling
por: Salazar, María, et al.
Publicado: (2015)

Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
por: Shen, Li, et al.
Publicado: (2012)

Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma
por: Yoshitake, Ryohei, et al.
Publicado: (2020)

Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer
por: Ijichi, Hideaki
Publicado: (2012)

Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
por: Rathore, Richa, et al.
Publicado: (2021)

Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014)

Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE(2) Mediated JAK2/STAT3 Signaling Pathway
por: Liu, Xuan, et al.
Publicado: (2015)

CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma
por: Tardáguila, Manuel, et al.
Publicado: (2013)

Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE(2) expression
por: Wang, Huiqiang, et al.
Publicado: (2015)

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies
por: Rossig, Claudia
Publicado: (2012)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5q9n6iv4mm38v5h7jsf08mebpp